⌘K

Login Start Free

Home/Filings/4/0001209191-23-031840

4//SEC Filing

Sigal Charles Elliott 4

Accession 0001209191-23-031840

CIK 0001706431other

View on SEC.gov Company Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 2:33 PM ET

Size

11.1 KB

Accession

0001209191-23-031840

Insider Transaction Report

Form 4

Period: 2023-05-22

Vir Biotechnology, Inc.VIR

Sigal Charles Elliott

Director

Transactions

Award
Stock Option (Right to Buy)
2023-05-22+12,054→ 12,054 total
Exercise: $25.74From: 2024-05-22Exp: 2033-05-21→ Common Stock (12,054 underlying)
Award
Common Stock
2023-05-22+6,027→ 15,806 total

Holdings

Common Stock
(indirect: See footnote)
10,000

Footnotes (1)

[F1]By Sigal Family Investments, LLC

Documents

2 files

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1

filerCIK 0001661908

Filing Metadata

Form type: 4
Filed: May 23, 8:00 PM ET
Accepted: May 24, 2:33 PM ET
Size: 11.1 KB

View on SEC.gov